Ortho Evra sales last year totaled $124 million, trailing Merck & Co. Inc.’s NuvaRing, which posted sales of $437 million, according to health care data firm IMS Health.

The numbers keep adding up for the Ortho Evra birth-control patch. Not sales - those are down sharply - but the docket of product liability cases filed against Johnson & Johnson, the maker of the ...

The FDA has taken two years to decide whether the Ortho Evra birth control patch should be withdrawn. Meanwhile, it's killing women. Meanwhile, it's killing women.

The maker and distributor of a widely used once-a-week birth control patch were the targets of lawsuits filed Wednesday in San Francisco by the mother of a 25-year-old woman who died after using ...

ORTHO EVRA has been a safe and effective birth control option for women and their healthcare providers since 2002. It addresses a birth control need and provides another choice for women who, with ...

Off your mind” slogan sent waves through the world of women’s health and college dormitories.But more than a year after the Ortho Evra birth control patch was released in the United States, it ...

Ortho Evra is a prescription patch that releases ethinyl estradiol (an estrogen hormone) and norelgestromin (a progestin hormone) through the skin into the blood stream.

Johnson & Johnson’s Ortho Evra contraceptive patch will come with a new warning about a study suggesting users could face twice the risks of blood clots compared with birth control pills, the ...

J&J;’s willingness to settle Ortho Evra lawsuits contrasts with Merck & Co.’s stance on the 11,500 suits it faces over painkiller Vioxx, which is linked to heart attacks and strokes.

When Ortho Evra first hit the market in 2002, it was a big hit. "Time" magazine called it one of the best inventions of the year and doctors have written nearly 40 million prescriptions for it.

Ortho-McNeil Knew Ortho-Evra Patch Was Lethal ... In addition, according to a November 11, 2005, article by the Associated Press, an internal company memo shows that in 2003, ...